Clinical Trial Update: Bi-Weekly Docetaxel Plus 24-Hour Infusion of High-Dose 5-Fluorouracil / Leucovorin (HDFL) for Inoperable Advanced or Metastatic Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bi-weekly docetaxel plus a 24-hour infusion of high-dose 5-fluorouracil with leucovorin for inoperable advanced or metastatic gastric c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• DOCETAXEL (DOCETAXEL)
• Leucovorin (folinic acid)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Gastric Cancer | Phase 2 | Status: TERMINATED